Yuan Zhi
Stock Analyst at B. Riley Securities
(2.00)
# 3,082
Out of 5,124 analysts
32
Total ratings
41.94%
Success rate
-4.32%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RADX Radiopharm Theranostics | Reiterates: Buy | $13 → $16 | $5.22 | +206.51% | 3 | Dec 16, 2025 | |
| RDNT RadNet | Maintains: Buy | $71 → $87 | $71.35 | +21.93% | 2 | Dec 1, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $8 → $14 | $8.86 | +58.01% | 3 | Nov 18, 2025 | |
| CATX Perspective Therapeutics | Maintains: Buy | $12 → $11 | $2.75 | +300.00% | 4 | Nov 18, 2025 | |
| MIR Mirion Technologies | Reiterates: Buy | $17 → $22 | $23.42 | -6.06% | 3 | Jul 23, 2025 | |
| TOI The Oncology Institute | Initiates: Buy | $6 | $3.56 | +68.54% | 1 | Jul 16, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.2 → $1 | $0.98 | +2.11% | 2 | May 15, 2025 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $3.14 | +473.25% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $9.60 | +56.25% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.64 | +369.26% | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $79 | $33.26 | +137.52% | 3 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $1.36 | +1,076.47% | 4 | Dec 11, 2023 |
Radiopharm Theranostics
Dec 16, 2025
Reiterates: Buy
Price Target: $13 → $16
Current: $5.22
Upside: +206.51%
RadNet
Dec 1, 2025
Maintains: Buy
Price Target: $71 → $87
Current: $71.35
Upside: +21.93%
Tango Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $8 → $14
Current: $8.86
Upside: +58.01%
Perspective Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $2.75
Upside: +300.00%
Mirion Technologies
Jul 23, 2025
Reiterates: Buy
Price Target: $17 → $22
Current: $23.42
Upside: -6.06%
The Oncology Institute
Jul 16, 2025
Initiates: Buy
Price Target: $6
Current: $3.56
Upside: +68.54%
Hyperfine
May 15, 2025
Maintains: Buy
Price Target: $1.2 → $1
Current: $0.98
Upside: +2.11%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $3.14
Upside: +473.25%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $9.60
Upside: +56.25%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.64
Upside: +369.26%
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $33.26
Upside: +137.52%
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.36
Upside: +1,076.47%